We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Seattle Genetics and Genmab Collaborate

News   Sep 12, 2014

 
Seattle Genetics and Genmab Collaborate
 
 
Advertisement
 

RELATED ARTICLES

Data Shows Pfizer-BioNTech COVID-19 Vaccine Provides Protection From First Dose

News

An independent analysis conducted by Public Health England (PHE) in the UK demonstrates that the Pfizer-BioNTech COVID-19 vaccine BNT162b2 provides protection against infection and asymptomatic disease after the first dose.

READ MORE

HER2 Breast Cancer Cells Adopt Strategy To Resist Immunotherapy

News

Findings from a study published in Nature Communications reveal how cancer cells escape death by lymphocytes through the disruption of interferon-gamma signaling.

READ MORE

Innate Immune System Can Make Things Worse in Severe COVID-19

News

In patients with severe COVID-19, the innate immune system overreacts. This overreaction may underlie the formation of blood clots (thrombi) and deterioration in oxygen saturation that affect the patients.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE